# Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

> **NCT00832494** · PHASE1,PHASE2 · COMPLETED · sponsor: **Antisoma Research** · enrollment: 105 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** DMXAA in combination with carboplatin and paclitaxel

## Key facts

- **NCT ID:** NCT00832494
- **Lead sponsor:** Antisoma Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2009-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832494, "Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00832494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*